| Name: | Anastrozole EP Impurity B |
| Catalogue No. | VL2490006 |
| CAS No. | 1216898-82-6 |
| Molecular Formula | C30H31N9 |
| Molecular Weight | 517.63 |
| Status | In-stock |
| IUPAC Name | 2,3-Bis[3-(1-cyano-1-methylethyl)-5-(1H,1,2,4-triazole-1-ylmethyl)phenyl]-2-methylpropionitrile |
| Synonyms | Anastrozole Dimer Impurity |
| Description | Anastrozole EP Impurity B (CAS No: 1216898-82-6) or :2,3-Bis[3-(1-cyano-1-methylethyl)-5-(1H,1,2,4-triazole-1-ylmethyl)phenyl]-2-methylpropionitrile,Anastrozole EP Impurity B is an impurity of Anastrozole. it is used in the treatment of postmenopausal women with estrogen-responsive breast cancer by decreasing circulating estrogen levels |
| References | Gangadhara, Sharath, and Gianfilippo Bertelli. “Long-Term Efficacy and Safety of Anastrozole for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women.” Therapeutics and Clinical Risk Management, vol. 5, 2009, pp. 291–300, www.ncbi.nlm.nih.gov/pmc/articles/PMC2690973/. |
